JP Morgan Maintains Neutral on Johnson & Johnson, Raises Price Target to $250
JP Morgan analyst Chris Schott maintains Johnson & Johnson (NYSE:JNJ) with a Neutral and raises the price target from $225 to $250.
Login to comment